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OBJECTIVES We sought to determine the prevalence of right bundle branch block (RBBB) and ST
segment elevation in the working Japanese population, as well as the event rate during a
three-year prospective follow-up period.
BACKGROUND A poor prognosis of RBBB and ST segment elevation has been reported in Europe and South
America, even in asymptomatic patients; however, a large population of asymptomatic
patients with sporadic RBBB and ST segment elevation has not been studied.
METHODS Ten thousand 12-lead electrocardiograms (ECGs) were obtained during annual check-ups of
working adults in the Tokyo area. This three-year prospective follow-up study consisted of
105 patients, including 20 with ventricular fibrillation, 18 with syncope and 67 who were
asymptomatic. They were registered from 46 institutions in Japan.
RESULTS The prevalence of ECG abnormalities in working adults was 0.16%. A coved-type ST segment
elevation was related to a history of cardiac events, and 18% of registered patients had PR
prolongation and 9.5% had left-axis deviation. The cumulative cardiac event-free rate was 67.6%
in the symptomatic group and 93.4% in the asymptomatic group (p 5 0.0004) after three years.
CONCLUSIONS The recurrence rate of cardiac events in symptomatic patients was similar to that reported
previously, but it was very low in sporadic asymptomatic patients. The ECG findings may help us
to select patients for further examination and more accurate evaluation of their prognoses. (J Am
Coll Cardiol 2001;37:1916–20) © 2001 by the American College of Cardiology
Brugada and Brugada (1) first reported a unique electrocar-
diographic (ECG) syndrome in which ventricular fibrilla-
tion (VF) could occur without obvious structural heart
disease. Their report drew attention to this condition, and
Brugada syndrome has subsequently been recognized in
virtually all parts of the world (2,3), although its incidence
and distribution remain unclear. We previously reported on
the clinical characteristics of 63 Japanese patients who had
ECG evidence of right bundle branch block (RBBB)
associated with ST segment elevation in the right precordial
leads (4). At that time, we determined the incidence of
cardiac events in these patients. Subsequently, we continued
to enroll new patients and conducted a three-year follow-up
study. In addition, to elucidate the incidence of the unique
Brugada-type ECG pattern in working Japanese adults, we
reviewed 10,000 consecutive ECGs.
METHODS
To determine the prevalence of RBBB associated with ST
segment elevation in working Japanese adults, 10,000 con-
secutive standard 12-lead ECGs were obtained at the
annual medical check-ups of the personnel of an electrical
company and a pharmaceutical company in the Tokyo area.
The age of the employees undergoing assessment ranged
from 20 to 66 years (mean 42 6 9); there were 8,913 men
and 1,087 women. The ECGs were reviewed by two
cardiologists simultaneously, and if they did not agree, the
diagnosis was not accepted.
Electrocardiographic definitions. Complete RBBB was
defined as a QRS duration $0.12 s, with an RsR9 config-
uration; incomplete RBBB was defined as a QRS duration
$0.10 s, with an rSr9 configuration in the right precordial
leads. ST segment elevation was defined as high take-off
elevation of the J point of at least 0.1 mV in leads V1 to V3.
Registration and follow-up. Prospective follow-up of pa-
tients with RBBB and ST segment elevation in the right
precordial leads was initiated in April 1994. Information
was recorded on designated forms that contained demo-
graphic, ECG, historical and therapeutic data. The ECGs
were obtained from all patients at the time of registration.
Patients qualified for registration if the elevated ST seg-
ments had a coved or saddle-back shape (4). The patients
were classified into the following three groups: the VF
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group, with a history of documented VF; the syncope group,
with one or more syncopal attacks; and the asymptomatic
group, with neither VF nor syncope.
For each patient enrolled in this study, prospective
follow-up was performed, and the following information
was recorded at each review: any recurrence of syncopal
attacks; the cause of death, if this occurred during follow-
up; and a 12-lead ECG. Follow-up information was ob-
tained for all patients every six months after registration.
From April 1994 to the end of December 1995, 129
patients were registered at the registration center (First
Department of Internal Medicine, Nippon Medical School,
Tokyo). The patients were enrolled from 46 institutions in
Japan (see Appendix). All of them underwent a physical
examination, chest radiography, 12-lead electrocardiogra-
phy and M-mode or two-dimensional echocardiography.
All of the ECGs were reviewed by two investigators, and 24
patients were excluded from follow-up because ST segment
elevation was not obvious in the right precordial leads or
because they had other heart diseases, or both. Thus, 105
patients were enrolled for three-year follow-up. Upon phys-
ical examination and echocardiography, none of these pa-
tients had any obvious underlying heart disease. There was
no evidence of electrolyte abnormalities in any of the
patients at registration.
Statistical analysis. All data are expressed as the mean
value 6 standard deviation. A frequency comparison was
performed by using the chi-square test with Yates’ correc-
tion. A two-tailed p value ,0.05 was considered to indicate
significance. The probabilities of survival and event-free
survival were estimated by the Kaplan-Meier method, and
the significance of differences was calculated by using the
log-rank test.
RESULTS
Prevalence of ECG abnormalities. Among the 10,000
working adults, a total of 243 (2.4%; 235 men and 8
women) had incomplete RBBB, and 77 (0.77%: 73 men and
4 women) had complete RBBB. Only 16 men (0.16%), and
none of the women, had obvious ST segment elevation in
the right precordial leads. Five of the men were registered
for follow-up, but the other 11 did not agree to enter the
study. None of the subjects with complete RBBB had ST
segment elevation in the right precordial leads (Table 1).
Clinical and ECG characteristics. The clinical features
and the pattern of ST segment elevation in the right
precordial leads of the 105 patients (average age 45 6 13
years) enrolled for follow-up are presented in Table 2. There
were only six women: one in the syncope group and five in
the asymptomatic group. At the time of registration, coved-
type ST segment elevation was more frequently observed in
the VF group (85%) and in the syncope group (61.1%) than
in the asymptomatic group (38.8%). Five of the 105 subjects
had a family history of sudden death (SD). These deaths
include the cousin of a 38-year-old man in the VF group,
the twin sibling of a 48-year-old man in the syncope group
and the sibling of a 69-year-old man in the asymptomatic
group.
Twenty patients had at least one episode of documented
VF before registration, and 18 had at least one episode of
syncope, whereas the remaining 67 asymptomatic subjects
had experienced neither VF nor syncope. Their age distri-
bution showed a peak in the early 50s, with the majority of
Abbreviations and Acronyms
ECG 5 electrocardiogram or electrocardiographic
ICD 5 implantable cardioverter-defibrillator
RBBB 5 right bundle branch block
SD 5 sudden death
VF 5 ventricular fibrillation
Table 1. Frequency of Right Bundle Branch Block and ST Segment Elevation in the Right Precordial Leads (V1 to V3) in a Japanese
Working Population in the Tokyo Metropolitan Area
Age (yr)
No. of ECGs Complete RBBB Incomplete RBBB
Incomplete RBBB and
ST Segment Elevation
in Leads V1 to V3
n Men Women n Men Women n Men Women n Men Women
20–29 1,145 718 427 4 2 2 14 12 2 1 1 0
30–39 2,109 1,890 219 9 9 0 49 48 1 6 6 0
40–49 4,778 4,462 316 40 39 1 116 114 2 6 6 0
50–59 1,919 1,799 120 24 23 1 64 61 3 3 3 0
60–69 49 44 5 0 0 0 0 0 0 0 0 0
Total 10,000 8,913 1,087 77 73 4 243 235 8 16 16 0
ECG 5 electrocardiogram; RBBB 5 right bundle branch block.
Table 2. Clinical Background of Patients With Right Bundle
Branch Block and ST Segment Elevation (Leads V1 to V3)
Baseline Characteristics and
Type of ST Segment
Elevation
VF
Group
(n 5 20)
Syncope
Group
(n 5 18)
Asymptomatic
Group
(n 5 67)
Age (yr) 41 6 10 47 6 13 45 6 14
Men 20 17 62
Women 0 1 5
Type of ST segment elevation
Coved type 17 11 26
Saddle-back type 3 7 41
Data are presented as the mean value 6 SD or number of patients.
VF 5 ventricular fibrillation.
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the patients in their late 30s to early 60s. Symptomatic
patients with at least one cardiac event (VF or syncope) were
most frequently in their late 40s, whereas a large majority of
the patients without any cardiac events were in their 50s to
early 60s (Fig. 1).
On the 12-lead ECG, all 105 registered patients had
RBBB and ST segment elevation of .0.1 mV in leads V1 to
V3. At registration, 54 ECGs (51.4%) showed coved-type
ST segment elevation, and the remaining 51 ECGs showed
saddle-back ST segment elevation. Coved-type ST segment
elevation was most frequent in the VF group (85%), but was
still seen in 38.8% of the asymptomatic group. When the
patients were classified into two groups, the frequency of the
coved type was significantly higher in the symptomatic
group than in the asymptomatic group (p 5 0.0001). On
the ECG, 18.1% also had PR prolongation (PR interval
$0.22 s), and 9.5% had left-axis deviation (a frontal plane
QRS axis between 230° to 290°). These findings were
more frequent in patients with a history of cardiac events,
but the differences were not statistically significant (Table 3).
Follow-up data. During the three-year follow-up, nine
patients dropped out and did not visit the hospital for
review. All nine patients were asymptomatic at the time of
registration, with an abnormal ECG detected incidentally at
their annual medical check-ups. During the three-year
follow-up, a total five patients died: two patients in the VF
group died suddenly; two asymptomatic patients died of
cancer; and one asymptomatic patient died of an unknown
cause. Seven patients had placement of an implantable
cardioverter-defibrillator (ICD) because of the recurrence of
VF, or because of new VF in one asymptomatic patient.
Figure 2 shows the Kaplan-Meier curves for survival with-
out any cardiac events, including sustained ventricular ar-
rhythmias or syncope. The symptomatic patients are com-
pared with the asymptomatic patients. The cumulative
cardiac event-free survival rate was 67.6% in the symptom-
atic groups and 93.4% in the asymptomatic group (log-rank
test; p 5 0.0004) after three years. Figure 3 also shows the
Kaplan-Meier survival curves for the symptomatic and
asymptomatic groups. The survival rates were 74.7% in the
symptomatic group and 92.2% in the asymptomatic group
(log-rank test; p 5 0.017). There was a significantly higher
rate of cardiac events and death from all causes in symp-
tomatic patients during the follow-up period.
DISCUSSION
It is important to elucidate the prevalence of ECG abnor-
malities related to Brugada syndrome and to determine the
prognosis of these patients. In this study, we investigated
the prevalence of Brugada syndrome, as demonstrated by
electrocardiography, and we also performed three-year
follow-up.
Prevalence of ECG abnormalities. The prevalence of
complete RBBB is 2.2% and that of incomplete RBBB is
1.7% in patients at a general hospital in Japan (5). These
values are comparable to those reported by Katz and Pick (6)
(2.3% and 1.1%, respectively). It has also been reported that
the population-based prevalence of isolated, complete
RBBB was in the range of only 0.18% to 0.35% (7,8) and
Figure 1. Bar graph showing the age distribution of the 105 patients with
RBBB and ST segment elevation in the right precordial leads. The VF,
syncope and asymptomatic patients in each age group are identified by
different bar patterns.
Table 3. Electrocardiographic Characteristics
n 5 105
Coved Type
(n 5 54 [51.4%])
Saddle-Back Type
(n 5 51 [48.6%])
PR Prolongation
(n 5 19 [18.1%])
Left-Axis Deviation
(n 5 10 [9.5%])
Symptomatic group 38 28 (73.7%) 10 (26.3%) 10 (26.3%) 6 (15.8%)
VF 20 17 (85%) 3 (15%) 5 (25%) 1 (5%)
Syncope 18 11 (61.1%) 7 (38.9%) 5 (27.8%) 5 (27.8%)
Asymptomatic group 67 26 (38.8%) 41 (61.2%) 9 (13.4%) 4 (6.0%)
Data are presented as number (%) of patients.
VF 5 ventricular fibrillation.
Figure 2. Kaplan-Meier curves for survival without cardiac events (includ-
ing sustained ventricular arrhythmias or syncope) in the symptomatic and
asymptomatic groups.
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that of electrocardiographically demonstrated Brugada syn-
drome was 0.1% in an apparently healthy population in
Europe (9). In Japan, an adult population study has shown
that the incidence of RBBB associated with ST segment
elevation in leads V1 to V3 was 0.05%, although it was even
less frequent in children (10). In the present study, we
assessed the prevalence in working Japanese adults because
the unexpected death of workers is becoming an important
social problem. It may be difficult to project directly to the
general population. The prevalence of a Brugada-type ECG
abnormality in working Japanese adults is 0.16%, similar to
that found in a European population study (9). Among the
105 subjects registered for follow-up, all had RBBB and ST
segment elevation in the right precordial leads, and some
also had PR prolongation (18.1%) or left-axis deviation
(9.5%). These ECG findings were more frequent in patients
with a history of cardiac events. These findings may support
the existence of an underlying conduction abnormality in
this syndrome (1).
Three-year follow-up. The prognosis of Brugada syn-
drome has been investigated in Europe and South America.
Brugada et al. (11) reported a very poor prognosis of this
syndrome even in asymptomatic patients. They studied 63
patients with the typical ECG pattern. During a mean
follow-up period of 34 months, an arrhythmic event oc-
curred in 34% of the symptomatic patients and in 27% of
the asymptomatic patients. In Thailand, sudden unex-
plained death syndrome, with an accompanying ECG
abnormality like Brugada syndrome, also seems to occur at
a higher incidence in patents with previous cardiac events
(12). Our study demonstrated a lower incidence of arrhyth-
mic events, especially in asymptomatic patients. Among 67
asymptomatic patients, only one patient (1.5%) had an
episode of VF and received an ICD during three-year
follow-up. In contrast, the symptomatic patients who had a
history of VF or syncope developed arrhythmic events far
more frequently (25.7%), and their event rate was not much
different from that of European patients (11). In our
Japanese asymptomatic group, however, the event rate was
lower than that of European patients. In the European
follow-up study (11), the asymptomatic group included
more family members affected with Brugada syndrome, and
fewer sporadic patients, than the present study (only two of
our patients had a family history of syncope or SD). In our
series of asymptomatic patients, the majority of cases were
sporadic, and only one of them died suddenly of an
unknown cause during the follow-up period. Of course,
even one SD in 67 (1.5%) may seem important for physi-
cians. Nearly half a century ago, an ECG abnormality
similar to Brugada syndrome was described. Osher and
Wolff (13), as well as Edeiken (14), reported ST-segment
elevation in young men; the magnitude of the ST segment
elevation varied spontaneously and persisted with no car-
diovascular events for months or even up to five years. They
concluded that this ST segment elevation was not necessar-
ily indicative of myocardial disease, but may represent a
normal variant. Since then, many physicians have consid-
ered that such ECG findings are a normal variant that does
not need further investigation in patients with no obvious
cardiovascular abnormalities upon physical examination and
echocardiography. In the future, however, we have to follow
up these patients more carefully, even if they have no family
history of SD or Brugada syndrome.
Study limitations. The present study did not assess elec-
trophysiologic data, because in asymptomatic patients, we
could not perform electrophysiologic studies. We also did
not investigate the drug prescribed for the subjects. After a
three-year prospective follow-up period, a cardiac event
developed in only one subject from the asymptomatic group,
so longer follow-up may be necessary to accurately investi-
gate the prognosis of asymptomatic patients.
Conclusions. The present study assessed the prevalence of
ECG abnormalities related to Brugada syndrome in work-
ing Japanese adults. Also, a prospective three-year study was
performed in 105 patients with this condition. The cumu-
lative event-free rate was significantly lower in symptomatic
patients than in asymptomatic patients. We concluded that
RBBB plus ST segment elevation might be associated with
a lower cardiac event rate than previously expected in
individuals who have an apparently normal heart, with no
family history of SD. However, they should be followed up
more carefully than before, when they were considered to be
a normal variant. The ECG findings, such as coved-type ST
segment elevation, PR prolongation and left-axis deviation,
may help us to identify patients for further examination and
more accurate evaluation of their prognosis.
APPENDIX
Idiopathic Ventricular Fibrillation Investigators: S.
Ogawa (Chairman), H. Atarashi, K. Harumi, H. Hay-
akawa, T. Sugimoto, R. Okada, M. Murayama, J. Toyama,
Y. Aizawa, H. Inoue, H. Kasanuki, T. Ohe and T. Iwa.
For a complete list of institutions and investigators that
participated in this multicenter study, please see the June 1
issue of JACC at www.cardiosource.com.
Figure 3. Kaplan-Meier curves for survival in the symptomatic and
asymptomatic groups. The calculations were based on all causes of death.
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